The “Proteoglycans in cancer” pathway was also exclusively enriched in AA-SScL fibroblasts, driven by the upregulation of IGF2, DCN, LUM, COL1A1, COL1A2, and the receptors KDR and TLR4. The gene discussed is IGF2; the disease is cancer.